RadNet Gross Profit 2010-2025 | RDNT

RadNet gross profit from 2010 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
RadNet Annual Gross Profit
(Millions of US $)
2024 $249
2023 $221
2022 $166
2021 $192
2020 $106
2019 $154
2018 $108
2017 $120
2016 $109
2015 $101
2014 $115
2013 $104
2012 $104
2011 $107
2010 $98
2009 $130
RadNet Quarterly Gross Profit
(Millions of US $)
2025-03-31 $18
2024-12-31 $66
2024-09-30 $69
2024-06-30 $70
2024-03-31 $44
2023-12-31 $64
2023-09-30 $60
2023-06-30 $59
2023-03-31 $39
2022-12-31 $54
2022-09-30 $36
2022-06-30 $49
2022-03-31 $27
2021-12-31 $48
2021-09-30 $60
2021-06-30 $50
2021-03-31 $33
2020-12-31 $50
2020-09-30 $45
2020-06-30 $-4
2020-03-31 $14
2019-12-31 $45
2019-09-30 $38
2019-06-30 $43
2019-03-31 $28
2018-12-31 $24
2018-09-30 $34
2018-06-30 $34
2018-03-31 $16
2017-12-31 $35
2017-09-30 $29
2017-06-30 $31
2017-03-31 $24
2016-12-31 $33
2016-09-30 $32
2016-06-30 $25
2016-03-31 $20
2015-12-31 $28
2015-09-30 $33
2015-06-30 $28
2015-03-31 $12
2014-12-31 $29
2014-09-30 $31
2014-06-30 $31
2014-03-31 $24
2013-12-31 $30
2013-09-30 $23
2013-06-30 $28
2013-03-31 $23
2012-12-31 $22
2012-09-30 $27
2012-06-30 $29
2012-03-31 $27
2011-12-31 $25
2011-09-30 $25
2011-06-30 $29
2011-03-31 $28
2010-12-31 $6
2010-09-30 $33
2010-06-30 $33
2010-03-31 $26
2009-12-31 $36
2009-09-30 $31
2009-06-30 $31
2009-03-31 $31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $4.296B $1.830B
RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $18.646B 18.38
Encompass Health (EHC) United States $11.080B 23.49
DaVita (DVA) United States $10.587B 14.89
Elanco Animal Health (ELAN) United States $7.206B 15.44
Chemed (CHE) United States $6.690B 21.02
Option Care Health (OPCH) United States $4.975B 22.18
Amedisys (AMED) United States $3.199B 21.52
Addus HomeCare (ADUS) United States $1.995B 21.91
LifeStance Health (LFST) United States $1.711B 0.00
Astrana Health (ASTH) United States $1.417B 35.11
U.S Physical Therapy (USPH) United States $1.120B 28.91
Pennant (PNTG) United States $0.819B 30.08
Aveanna Healthcare Holdings (AVAH) United States $0.778B 44.33
Atai Life Sciences (ATAI) Germany $0.541B 0.00
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.039B 0.00
Ontrak (OTRK) United States $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00